BME — BLACKROCK HEALTH SCIENCES TR
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BME?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their BME position last quarter, 1 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).
- +1 tracked investor added or increased positions last quarter (Ken Griffin)
- +1 tracked investors reported holding BME at their latest filing
- +Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.
About BLACKROCK HEALTH SCIENCES TR (BME)
BLACKROCK HEALTH SCIENCES TR (BME) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $528,150. Across recent filings, tracked investors recorded 3 new positions, 0 increased, 2 reduced, and 2 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BME
How many top investors track BME
Only 1 tracked investor report this position.
BME Ownership Composition
How BLACKROCK HEALTH SCIENCES TR is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting BME
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinJun 30, 2026Citadel AdvisorsShares8.3KValue$354.9K% Portfolio0.00%
Previously held BME
These investors reported BME in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Izzy Englander | Millennium Management | 10.4K | $429.5K | Dec 31, 2025 |
Recent activity
- Reduced$394.3K(-27.26%)Nov 14, 2024
- Reduced$267.5K(-25.01%)Feb 14, 2025
- Sold$0(-100.00%)May 15, 2025
- $429.5KFeb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- New$354.9KAug 14, 2026
- $306KMay 15, 2024
Frequently asked questions
- How many institutional investors hold BME?
- 1 tracked institutional investor disclosed a position in BME (BLACKROCK HEALTH SCIENCES TR) in their most recent 13F filing.
- Who is the largest institutional holder of BME?
- Izzy Englander, Millennium Management, holds the largest disclosed position in BME, valued at $528,150.
- Did institutional ownership of BME increase or decrease?
- Across recent 13F filings, tracked investors recorded 3 new positions, 0 increased, 2 reduced, and 2 fully exited BME.
- Where does this BME ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.